Yuqi Zhang1, Jaap J van Netten1,2, Mendel Baba3, Qinglu Cheng4, Rosana Pacella5, Steven M McPhail1,6, Susanna Cramb1, Peter A Lazzarini7,8. 1. Australian Centre for Health Services Innovation and Centre for Healthcare Translation, School of Public Health and Social Work, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, Brisbane, QLD, Australia. 2. Amsterdam UMC, University of Amsterdam, Department of Rehabilitation, Amsterdam Movement Sciences, Meibergdreef 9, Amsterdam, the Netherlands. 3. Podiatry Department, Sir Charles Gairdner Hospital, Perth, Australia. 4. The Kirby Institute, University of New South Wales, Sydney, Australia. 5. Institute for Lifecourse Development, University of Greenwich, London, UK. 6. Clinical Informatics Directorate, Metro South Health, Brisbane, Australia. 7. Australian Centre for Health Services Innovation and Centre for Healthcare Translation, School of Public Health and Social Work, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, Brisbane, QLD, Australia. peter.lazzarini@health.qld.gov.au. 8. Allied Health Research Collaborative, The Prince Charles Hospital, Brisbane, Australia. peter.lazzarini@health.qld.gov.au.
Abstract
BACKGROUND: Diabetes-related foot disease (DFD) is a leading cause of global hospitalisation, amputation and disability burdens; yet, the epidemiology of the DFD burden is unclear in Australia. We aimed to systematically review the literature reporting the prevalence and incidence of risk factors for DFD (e.g. neuropathy, peripheral artery disease), of DFD (ulcers and infection), and of diabetes-related amputation (total, minor and major amputation) in Australian populations. METHODS: We systematically searched PubMed and EMBASE databases for peer-reviewed articles published until December 31, 2019. We used search strings combining key terms for prevalence or incidence, DFD or amputation, and Australia. Search results were independently screened for eligibility by two investigators. Publications that reported prevalence or incidence of outcomes of interest in geographically defined Australian populations were eligible for inclusion. Included studies were independently assessed for methodological quality and key data were extracted by two investigators. RESULTS: Twenty publications met eligibility and were included. There was high heterogeneity for populations investigated and methods used to identify outcomes. We found within diabetes populations, the prevalence of risk factors ranged from 10.0-58.8%, of DFD from 1.2-1.5%, and the incidence of diabetes-related amputation ranged from 5.2-7.2 per 1000 person-years. Additionally, the incidence of DFD-related hospitalisation ranged from 5.2-36.6 per 1000 person-years within diabetes populations. Furthermore, within inpatients with diabetes, we found the prevalence of risk factors ranged from 35.3-43.3%, DFD from 7.0-15.1% and amputation during hospitalisation from 1.4-5.8%. CONCLUSIONS: Our review suggests a similar risk factor prevalence, low but uncertain DFD prevalence, and high DFD-related hospitalisation and amputation incidence in Australia compared to international populations. These findings may suggest that a low proportion of people with risk factors develop DFD, however, it is also possible that there is an underestimation of DFD prevalence in Australia in the few limited studies, given the high incidence of hospitalisation and amputation because of DFD. Either way, studies of nationally representative populations using valid outcome measures are needed to verify these DFD-related findings and interpretations.
BACKGROUND:Diabetes-related foot disease (DFD) is a leading cause of global hospitalisation, amputation and disability burdens; yet, the epidemiology of the DFD burden is unclear in Australia. We aimed to systematically review the literature reporting the prevalence and incidence of risk factors for DFD (e.g. neuropathy, peripheral artery disease), of DFD (ulcers and infection), and of diabetes-related amputation (total, minor and major amputation) in Australian populations. METHODS: We systematically searched PubMed and EMBASE databases for peer-reviewed articles published until December 31, 2019. We used search strings combining key terms for prevalence or incidence, DFD or amputation, and Australia. Search results were independently screened for eligibility by two investigators. Publications that reported prevalence or incidence of outcomes of interest in geographically defined Australian populations were eligible for inclusion. Included studies were independently assessed for methodological quality and key data were extracted by two investigators. RESULTS: Twenty publications met eligibility and were included. There was high heterogeneity for populations investigated and methods used to identify outcomes. We found within diabetes populations, the prevalence of risk factors ranged from 10.0-58.8%, of DFD from 1.2-1.5%, and the incidence of diabetes-related amputation ranged from 5.2-7.2 per 1000 person-years. Additionally, the incidence of DFD-related hospitalisation ranged from 5.2-36.6 per 1000 person-years within diabetes populations. Furthermore, within inpatients with diabetes, we found the prevalence of risk factors ranged from 35.3-43.3%, DFD from 7.0-15.1% and amputation during hospitalisation from 1.4-5.8%. CONCLUSIONS: Our review suggests a similar risk factor prevalence, low but uncertain DFD prevalence, and high DFD-related hospitalisation and amputation incidence in Australia compared to international populations. These findings may suggest that a low proportion of people with risk factors develop DFD, however, it is also possible that there is an underestimation of DFD prevalence in Australia in the few limited studies, given the high incidence of hospitalisation and amputation because of DFD. Either way, studies of nationally representative populations using valid outcome measures are needed to verify these DFD-related findings and interpretations.
Authors: Julia R Kurowski; Lee Nedkoff; Deborah E Schoen; Matthew Knuiman; Paul E Norman; Tom G Briffa Journal: Diabetes Res Clin Pract Date: 2015-02-21 Impact factor: 5.602
Authors: Peter A Lazzarini; Sheree E Hurn; Suzanne S Kuys; Maarten C Kamp; Vanessa Ng; Courtney Thomas; Scott Jen; Ewan M Kinnear; Michael C d'Emden; Lloyd Reed Journal: BMJ Open Date: 2016-06-20 Impact factor: 2.692
Authors: Maria Narres; Tatjana Kvitkina; Heiner Claessen; Sigrid Droste; Björn Schuster; Stephan Morbach; Gerhard Rümenapf; Kristien Van Acker; Andrea Icks Journal: PLoS One Date: 2017-08-28 Impact factor: 3.240
Authors: Michelle R Kaminski; Jonathan Golledge; Joel W J Lasschuit; Karl-Heinz Schott; James Charles; Jane Cheney; Anita Raspovic Journal: J Foot Ankle Res Date: 2022-07-06 Impact factor: 3.050
Authors: Pamela Chen; Keryln Carville; Terry Swanson; Peter A Lazzarini; James Charles; Jane Cheney; Jenny Prentice Journal: J Foot Ankle Res Date: 2022-05-25 Impact factor: 3.050
Authors: Peter A Lazzarini; Anita Raspovic; Jenny Prentice; Robert J Commons; Robert A Fitridge; James Charles; Jane Cheney; Nytasha Purcell; Stephen M Twigg Journal: J Foot Ankle Res Date: 2022-04-19 Impact factor: 3.050
Authors: Malindu E Fernando; Mark Horsley; Sara Jones; Brian Martin; Vanessa L Nube; James Charles; Jane Cheney; Peter A Lazzarini Journal: J Foot Ankle Res Date: 2022-05-05 Impact factor: 3.050
Authors: Sean Sadler; James Gerrard; Matthew West; Sean Lanting; James Charles; Angela Searle; Vivienne Chuter Journal: J Foot Ankle Res Date: 2022-07-22 Impact factor: 3.050